# The successful management of a cardia hamartomatous inverted polyp via endoscopic submucosal dissection: a case report

**Authors:** Xu Zhang, Hong-nian Pan, Xiu-zhong Wang, Mei Li, Jie Liu, Xiao-yan Liu

PMC · DOI: 10.3389/fsurg.2025.1682095 · 2025-10-09

## TL;DR

A rare case of a cardia hamartomatous inverted polyp was successfully treated using endoscopic submucosal dissection.

## Contribution

This case report highlights the successful use of ESD for a rare and challenging gastric polyp variant.

## Key findings

- Endoscopic submucosal dissection enabled en bloc resection of the lesion without complications.
- Immunohistochemistry confirmed the diagnosis of cardia hamartomatous inverted polyp.
- The tumor was located in the submucosal layer and showed specific marker expression patterns.

## Abstract

A gastric hamartomatous inverted polyp (GHIP) is an uncommon submucosal neoplasm that is histopathologically defined by a submucosal inverted growth of cystically dilated hyperplastic gastric glands.

A 74-year-old Chinese man presented with a submucosal tumor (SMT) in the cardia, identified through electronic gastroscopy. This report presents a case of cardia hamartomatous inverted polyp (CHIP), which represent a rare histological variant of gastric polyps that pose diagnostic challenges. The endoscopic examination revealed the presence of a submucosal tumor, and endoscopic ultrasonography indicated a heterogeneous tumor predominantly situated within the third (submucosal) layer. Immunohistochemistry outcomes indicated MUC5AC (+), MUC6 (+), Syn (+), Ki-67 (+, approximately 5%), Desmin (+), SMA (+), as well as MUC2 (−). To achieve en bloc resection for lesions >1.0 cm, endoscopic submucosal dissection (ESD) was performed. The pathological evaluation confirmed the diagnosis of CHIP. The patient was discharged without experiencing any complications.

Therefore, the ESD approach may be particularly suitable for the management of SMT-type hamartomatous inverted polyps.

## Linked entities

- **Proteins:** MUC5AC (mucin 5AC, oligomeric mucus/gel-forming), MUC6 (mucin 6, oligomeric mucus/gel-forming (gene/pseudogene)), FYN (FYN proto-oncogene, Src family tyrosine kinase), Mki67 (antigen identified by monoclonal antibody Ki 67), LOC101066771 (desmin-like), SMN1 (survival of motor neuron 1, telomeric), MUC2 (mucin 2, oligomeric mucus/gel-forming)

## Full-text entities

- **Genes:** MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, SYNM (synemin) [NCBI Gene 23336] {aka DMN, SYN}, MUC6 (mucin 6, oligomeric mucus/gel-forming (gene/pseudogene)) [NCBI Gene 4588] {aka MUC-6}
- **Diseases:** CHIP (MESH:D011127), SMT (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12546118/full.md

---
Source: https://tomesphere.com/paper/PMC12546118